Mulberrofuran G

CAS No. 87085-00-5

Mulberrofuran G ( )

Catalog No. M31330 CAS No. 87085-00-5

Mulberrofuran G shows moderate activity, inhibits hepatitis B virus (HBV) DNA replication with the IC(50) value of 3.99 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 369 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Mulberrofuran G
  • Note
    Research use only, not for human use.
  • Brief Description
    Mulberrofuran G shows moderate activity, inhibits hepatitis B virus (HBV) DNA replication with the IC(50) value of 3.99 μM.
  • Description
    Mulberrofuran G shows moderate activity, inhibits hepatitis B virus (HBV) DNA replication with the IC(50) value of 3.99 μM.
  • Synonyms
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    87085-00-5
  • Formula Weight
    562.6
  • Molecular Formula
    C34H26O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sodium carbonate

    Sodium Carbonate, also named as Disodium carbonate, Soda Ash, Carbonic acid disodium salt, is the disodium salt of carbonic acid with alkalinizing property.

  • 6"-O-Apiosyl-5-O-Met...

    6”-O-Apiosyl-5-O-Methylvisammioside is one component of the traditional Chinese medicine Kang-Jing which has the functions of promoting blood circulation and dredging collaterals, dispersing wind and relieving pain.

  • ZINC77292789

    Fmoc-Thr[GalNAc(Ac)3-α-D]-OH is a reagent for the preparation of a synthetic MUC1 Glycopeptide Bearing βGalNAc-?Thr as a Tn antigen isomer which induces the antibody production against tumor cells. Fmoc-Thr[GalNAc(Ac)3-α-D]-OH is a starting material to make trimeric MUC1 immunodominant motif antigen-?based anti-?cancer vaccine candidates.